Latest News

Roflumilast foam effectively eases seborrheic dermatitis


 

FROM THE EADV CONGRESS

Lesson for practice: Advise patients to moisturize?

“It seems like the vehicle would be a good skincare product for patients,” observed the session’s cochair, Jo Lambert, MD, PhD, professor and academic head of the department of dermatology at Ghent University Hospital, Belgium.

It was “a pretty dramatic vehicle response, right?” Dr. Blauvelt responded. “We normally don’t think of telling seborrheic dermatitis patients to moisturize,” he added.

“I think one of the interesting findings is perhaps we should be telling them to moisturize their scalp or moisturize their face, or it could be something unique to this particular foam.”

The study was funded by Arcutis Biotherapeutics. Dr. Blauvelt disclosed that he was an investigator for the trial and acted as consultant to the company, receiving grants/research funding and/or honoraria. Several of the study’s co-investigators are employees of Arcutis. Dr. Lambert was not involved in the study and cochaired the late-breaking session during which the STRATUM trial findings were reported.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

A 64-year-old woman presents with a history of asymptomatic erythematous grouped papules on the right breast
MDedge Dermatology
Can dietary tweaks improve some skin diseases?
MDedge Dermatology
​​​​​​​A healthy White male presented with a rash consisting of erythematous to purpuric macules
MDedge Dermatology
FDA acts against sales of unapproved mole and skin tag products on Amazon, other sites
MDedge Dermatology
Does hidradenitis suppurativa worsen during pregnancy?
MDedge Dermatology
A 9-year-old girl was evaluated for a week-long history of rash on the feet
MDedge Dermatology
A White female presented with pruritic, reticulated, erythematous plaques on the abdomen
MDedge Dermatology
Why it’s important for dermatologists to learn about JAK inhibitors
MDedge Dermatology
Chlorophyll water can trigger pseudoporphyria, expert warns
MDedge Dermatology
Dupilumab offers ‘clinically meaningful’ improvements in prurigo nodularis
MDedge Dermatology